Role of the CDK inhibitor p27 (Kip1) in mammary development and carcinogenesis: Insights from knockout mice

被引:21
作者
Musgrove, EA [1 ]
Davison, EA [1 ]
Ormandy, CJ [1 ]
机构
[1] St Vincents Hosp, Garvan Inst Med Res, Canc Res Program, Darlinghurst, NSW 2010, Australia
基金
英国医学研究理事会;
关键词
p27 (Kip1); cyclin D1; ErbB2/Neu; mammary tumorigenesis; mammary development;
D O I
10.1023/B:JOMG.0000023588.55733.84
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The cyclin - dependent kinase inhibitor p27 (Kip1) is an important cell cycle regulatory gene in breast cancer, and decreased p27 expression is associated with poor prognosis. Some investigations of its role in mammary development have demonstrated reduced cyclin D1 expression and consequent lack of lobuloalveolar development, but others have found increased cyclin E-Cdk2 activity and increased proliferation balanced by increased apoptosis. It is unclear at present why these apparently divergent results have been obtained. Mice with reduced p27 gene dosage alone do not develop mammary carcinomas but do display substantially shorter tumor latency upon overexpression of erbB2, consistent with a role for p27 as a mammary tumor suppressor gene. In this review we summarize these and other data addressing the role of p27 in normal mammary epithelium and experimental models of mammary carcinogenesis.
引用
收藏
页码:55 / 66
页数:12
相关论文
共 74 条
[1]  
ARNAOUT A, 2004, J MAMMARY GLAND BIOL, V9, P67
[2]   p27Kip1 and p21Cip1 are not required for the formation of active D cyclin-cdk4 complexes [J].
Bagui, TK ;
Mohapatra, S ;
Haura, E ;
Pledger, WJ .
MOLECULAR AND CELLULAR BIOLOGY, 2003, 23 (20) :7285-7290
[3]   STOCHASTIC APPEARANCE OF MAMMARY-TUMORS IN TRANSGENIC MICE CARRYING THE MMTV/C-NEU ONCOGENE [J].
BOUCHARD, L ;
LAMARRE, L ;
TREMBLAY, PJ ;
JOLICOEUR, P .
CELL, 1989, 57 (06) :931-936
[4]   Suppression of Neu-induced mammary tumor growth in cyclin D1 deficient mice is compensated for by cyclin E [J].
Bowe, DB ;
Kenney, NJ ;
Adereth, Y ;
Maroulakou, IG .
ONCOGENE, 2002, 21 (02) :291-298
[5]  
Brodie S G, 2001, Trends Genet, V17, pS18, DOI 10.1016/S0168-9525(01)02451-9
[6]   Multiple genetic changes are associated with mammary tumorigenesis in Brca1 conditional knockout mice [J].
Brodie, SG ;
Xu, XL ;
Qiao, WH ;
Li, WM ;
Cao, L ;
Deng, CX .
ONCOGENE, 2001, 20 (51) :7514-7523
[7]   Expression of a truncated Brca1 protein delays lactational mammary development in transgenic mice [J].
Brown, MA ;
Nicolai, H ;
Howe, K ;
Katagiri, T ;
Lalani, E ;
Simpson, KJ ;
Manning, NW ;
Deans, A ;
Chen, P ;
Khanna, KK ;
Wati, MR ;
Griffiths, BL ;
Xu, CF ;
Stamp, GWH ;
Solomon, E .
TRANSGENIC RESEARCH, 2002, 11 (05) :467-478
[8]   Reversible G1 arrest induced by inhibition of the epidermal growth factor receptor tyrosine kinase requires up-regulation of p27KIP1 independent of MAPK activity [J].
Busse, D ;
Doughty, RS ;
Ramsey, TT ;
Russell, WE ;
Price, JO ;
Flanagan, WM ;
Shawver, LK ;
Arteaga, CL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (10) :6987-6995
[9]   Down-regulation of p21WAF1/CIP1 or p27Kip1 abrogates antiestrogen-mediated cell cycle arrest in human breast cancer cells [J].
Cariou, S ;
Donovan, JCH ;
Flanagan, WM ;
Milic, A ;
Bhattacharya, N ;
Slingerland, JM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (16) :9042-9046
[10]  
Carroll JS, 2003, CANCER RES, V63, P4322